"...the biggest savings are going to come through investment in the supply chain.” -Scott Spyker, CEO
Medina, OH (PRWEB) April 24, 2014
Scott Sheldon, LLC will be attending the 2014 Healthcare Supply Chain Summit by GHX. The 3-day Summit will take place May 5-May 7 in Philadelphia, Pennsylvania at the Philadelphia Marriott.
Due to the consulting firm’s passion and past supply chain engagements with Fortune 100 Healthcare companies, they believe their attendance will help them better serve their current and future customers.
“Knowing the ins and outs of an industry is key to evaluating and optimizing the supply chain for any business. Healthcare is especially complex and demands great attention to detail and a unique understanding of the dynamic industry. Providers, distributors, and manufacturers seek savings for their bottom line; cutting costs here and there will work short-term but the biggest savings are going to come through an investment in the supply chain,” Scott Spyker, CEO of Scott Sheldon, stated firmly, referring to his White Paper and theory on the future of healthcare.
The firm boasts a 5x ROI, at a minimum, for their supply chain consulting services, with plenty of customers realizing 15-20x the initial investment.
Look for Lora Holman, Business Development Manager, to represent the firm at the Summit.
The Healthcare Supply Chain Summit by GHX is the largest event for healthcare supply chain leaders. Now in its 14th year, the Summit offers a uniquely collaborative environment for both the buy and sell sides of the healthcare supply chain. Over 2-1/2 days, Summit attendees share strategies and solutions that significantly reduce costs while maintaining—and improving—patient outcomes.
If you’re interested in attending, you can find more information here.
About Scott Sheldon
Scott Sheldon, LLC is a global engineer of supply chain transformations across Healthcare & Life Sciences, CPG & Retail, and Manufacturing—and has been for over nine years. Their portfolio includes network optimizations, WMS implementations and clinical trial engagements for Multinational Healthcare Companies*, Pier 1 Imports, Rubbermaid and many other Fortune 500 companies.
*Due to confidentiality, we do not disclose the names of healthcare companies.